Acrodermatitis chronica atrophicans secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ACA}} | {{ACA}} | ||
{{CMG}}; {{AE}} {{Anahita]] | |||
==Overview== | |||
Proper [[antibiotic]] [[treatment]] of a [[patient]] who has been [[diagnosis|diagnosed]] with [[lyme disease]] can reduce the probability of [[acrodermatitis chronica atrophicans]]. | |||
==Secondary Prevention== | |||
Since [[acrodermatitis chronica atrophicans]] is a tertiary presentation of [[lyme disease]], proper [[antibiotic]] [[treatment]] of a [[patient]] who has been [[diagnosis|diagnosed]] with [[lyme disease]] can reduce the probability of [[acrodermatitis chronica atrophicans]].<ref name="pmid32512846">{{cite journal| author=Scott JD| title=Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada. | journal=Healthcare (Basel) | year= 2020 | volume= 8 | issue= 2 | pages= | pmid=32512846 | doi=10.3390/healthcare8020157 | pmc=7349802 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32512846 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs | [[Category:Needs review]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Revision as of 11:44, 17 June 2021
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans secondary prevention On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans secondary prevention |
|
FDA on Acrodermatitis chronica atrophicans secondary prevention |
|
CDC on Acrodermatitis chronica atrophicans secondary prevention |
|
Acrodermatitis chronica atrophicans secondary prevention in the news |
|
Blogs on Acrodermatitis chronica atrophicans secondary prevention |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {{Anahita]]
Overview
Proper antibiotic treatment of a patient who has been diagnosed with lyme disease can reduce the probability of acrodermatitis chronica atrophicans.
Secondary Prevention
Since acrodermatitis chronica atrophicans is a tertiary presentation of lyme disease, proper antibiotic treatment of a patient who has been diagnosed with lyme disease can reduce the probability of acrodermatitis chronica atrophicans.[1]
References
- ↑ Scott JD (2020). "Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada". Healthcare (Basel). 8 (2). doi:10.3390/healthcare8020157. PMC 7349802 Check
|pmc=value (help). PMID 32512846 Check|pmid=value (help).